Enfortumab Vedotin/Pembrolizumab Regimen

Preferred Label : Enfortumab Vedotin/Pembrolizumab Regimen;

NCIt synonyms : Pembrolizumab/Enfortumab Vedotin Regimen; Enfortumab Vedotin-Pembrolizumab; Enfortumab Vedotin-ejfv/Pembrolizumab Regimen; Enfortumab Vedotin-ejfv-Pembrolizumab; Keytruda/Padcev Regimen; Padcev/Keytruda Regimen; Enfortumab Vedotin Plus Pembrolizumab; Enfortumab Vedotin-ejfv Plus Pembrolizumab;

NCIt related terms : Enfortumab vedotin and Pembrolizumab;

NCIt definition : A regimen consisting of enfortumab vedotin and pembrolizumab that can be used for the treatment of bladder cancer.;

NCI Metathesaurus CUI : CL1922493;

Codes from synonyms : 120168;

Details

Origin ID

C203692;

UMLS CUI

C5909404;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Enfortumab Vedotin [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients